Budget impact analysis of the introduction of Rosiglitazone in the treatment of type-2 diabetes. The Italian NHS perspective

被引：0
|
作者：
Novelli, M [1 ]
Avallone, A [1 ]
Frizzo, V [1 ]
Bamfi, F [1 ]
机构：
[1] GlaxoSmithKline Inc, Verona, VR, Italy
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67631-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A158 / A158
页数：1
相关论文
共 50 条
  • [41] Prioritizing treatment preferences in patients with type 2 diabetes.
    Levine, MA
    El-Nahas, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P62 - P62
  • [42] Oralin as a meal insulin in treatment of Type 2 diabetes.
    Guevava, M
    Modi, P
    Guevara-Aguirre, J
    Saavedra, J
    Baldeon, G
    Moncayo, P
    Llore, L
    Benitez, E
    DIABETOLOGIA, 2002, 45 : A262 - A262
  • [43] Rosiglitazone produces long-term reductions in urinary albumin excretion in type 2 diabetes.
    Bakris, G
    Weston, WM
    Rappaport, EB
    Freed, MI
    DIABETOLOGIA, 1999, 42 : A230 - A230
  • [44] Acute reduction of fatty acids increases insulin secretion in type-2 diabetes.
    Qvigstad, E
    Mostad, LL
    Bjerve, K
    Grill, V
    DIABETOLOGIA, 1999, 42 : A153 - A153
  • [45] Rates and risk factors for type-2 diabetes among a cohort of women with a history of gestational diabetes.
    Russell, C
    Dodds, L
    Joseph, KS
    Armson, BA
    Kephart, G
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (11) : S120 - S120
  • [46] Obesity and Diabetes: The Impact of Bariatric Surgery on Type-2 Diabetes
    John B. Dixon
    World Journal of Surgery, 2009, 33
  • [47] Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review
    Malinowski, JM
    Bolesta, S
    CLINICAL THERAPEUTICS, 2000, 22 (10) : 1151 - 1168
  • [48] Obesity and Diabetes: The Impact of Bariatric Surgery on Type-2 Diabetes
    Dixon, John B.
    WORLD JOURNAL OF SURGERY, 2009, 33 (10) : 2014 - 2021
  • [49] A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt
    Gihan Hamdy Elsisi
    Ayman Afify
    Ashraf Abgad
    Ibtissam Zakaria
    Nabil Nasif
    Hani Naiem Ibrahim
    Nabil Raafat
    João L. Carapinha
    Cost Effectiveness and Resource Allocation, 20
  • [50] A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt
    Elsisi, Gihan Hamdy
    Afify, Ayman
    Abgad, Ashraf
    Zakaria, Ibtissam
    Nasif, Nabil
    Ibrahim, Hani Naiem
    Raafat, Nabil
    Carapinha, Joao L.
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2022, 20 (01)
12345